Suppr超能文献

相似文献

1
Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines.
Cancer Immunol Immunother. 2008 May;57(5):719-29. doi: 10.1007/s00262-007-0411-3. Epub 2007 Oct 13.
2
HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank.
Cancer Immunol Immunother. 2009 Sep;58(9):1507-15. doi: 10.1007/s00262-009-0701-z. Epub 2009 Apr 2.
3
Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
Int J Cancer. 2014 Jan 1;134(1):102-13. doi: 10.1002/ijc.28338. Epub 2013 Jul 16.
4
High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity.
Cancer Immunol Immunother. 2005 Feb;54(2):141-8. doi: 10.1007/s00262-004-0561-5. Epub 2004 Oct 1.
6
High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines.
Int J Cancer. 2000 Mar 1;85(5):697-702. doi: 10.1002/(sici)1097-0215(20000301)85:5<697::aid-ijc16>3.0.co;2-h.
7
Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts.
Cancer Sci. 2007 Jan;98(1):102-8. doi: 10.1111/j.1349-7006.2006.00356.x.
10
Different mechanisms can lead to the same altered HLA class I phenotype in tumors.
Tissue Antigens. 2007 Apr;69 Suppl 1:259-63. doi: 10.1111/j.1399-0039.2006.00776.x.

引用本文的文献

4
Exploring the potential of combining IL-2-activated NK cells with an anti-PDL1 monoclonal antibody to target multiple myeloma-associated macrophages.
Cancer Immunol Immunother. 2023 Jun;72(6):1789-1801. doi: 10.1007/s00262-022-03365-4. Epub 2023 Jan 19.
6
The immune-related role of beta-2-microglobulin in melanoma.
Front Oncol. 2022 Aug 16;12:944722. doi: 10.3389/fonc.2022.944722. eCollection 2022.
8
Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma.
Front Immunol. 2021 Mar 9;12:639636. doi: 10.3389/fimmu.2021.639636. eCollection 2021.
9
Roles of NK Cell Receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in Cancer.
Cancers (Basel). 2020 Jul 1;12(7):1755. doi: 10.3390/cancers12071755.
10
Unmasking of a primary desmoplastic melanoma tumour in the course of treatment of a metastatic disease with anti-PD-1 monoclonal antibody.
J Eur Acad Dermatol Venereol. 2019 Oct;33(10):e381-e383. doi: 10.1111/jdv.15675. Epub 2019 May 26.

本文引用的文献

2
MHC class I antigens and immune surveillance in transformed cells.
Int Rev Cytol. 2007;256:139-89. doi: 10.1016/S0074-7696(07)56005-5.
3
Cancer despite immunosurveillance: immunoselection and immunosubversion.
Nat Rev Immunol. 2006 Oct;6(10):715-27. doi: 10.1038/nri1936. Epub 2006 Sep 15.
4
Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population.
Cancer Immunol Immunother. 2007 Mar;56(3):371-9. doi: 10.1007/s00262-006-0193-z. Epub 2006 Jul 12.
6
LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.
Immunogenetics. 2006 Jul;58(7):503-10. doi: 10.1007/s00251-006-0111-8. Epub 2006 May 17.
7
ESTDAB: a collection of immunologically characterised melanoma cell lines and searchable databank.
Cancer Immunol Immunother. 2006 Jun;55(6):623-7. doi: 10.1007/s00262-005-0117-3. Epub 2006 Jan 19.
8
Immunosenescence, suppression and tumour progression.
Cancer Immunol Immunother. 2006 Aug;55(8):981-6. doi: 10.1007/s00262-005-0109-3. Epub 2005 Dec 6.
9
Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Tissue Antigens. 2005 May;65(5):419-28. doi: 10.1111/j.1399-0039.2005.00381.x.
10
High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity.
Cancer Immunol Immunother. 2005 Feb;54(2):141-8. doi: 10.1007/s00262-004-0561-5. Epub 2004 Oct 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验